Abstract 1256: B-cell infiltration is associated with survival outcomes in nivolumab-treated head and neck squamous cell carcinoma (HNSCC): NCT 03652142
Niki Gavrielatou(National and Kapodistrian University of Athens), Amanda Psyrri(National and Kapodistrian University of Athens), Ioannis G. Panayiotides(National and Kapodistrian University of Athens), Thazin Nwe Aung(Yale University), Periklis Foukas(National and Kapodistrian University of Athens), George Coukos(Ludwig Cancer Research), Ekaterina Fortis(Centre Hospitalier Universitaire Vaudois), David L. Rimm(Yale University), Μaria Anastasiou(National and Kapodistrian University of Athens), Aris Spathis(National and Kapodistrian University of Athens), Μαρία Γκοτζαμανίδου(National and Kapodistrian University of Athens), Ioannis Kotsantis(National and Kapodistrian University of Athens), Elena Vagia(Northwestern University), Ioannis Vathiotis(Yale University), Sylvie Rusakiewics, Panagiota Economopoulou(National and Kapodistrian University of Athens)
Cited by 0
Related Papers
PD-L1 as a biomarker of response to immune-checkpoint inhibitors
|Nature Reviews Clinical Oncology|2021|1.5k
Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma
|Nature|2005|1.5k
Rethinking ovarian cancer: recommendations for improving outcomes
|Nature reviews. Cancer|2011|1.5k
Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer
|Nature reviews. Cancer|2015|1.4k
Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features
|Proceedings of the National Academy of Sciences|2009|1.4k